Improving Clinical Trial Awareness and Recruitment

The pressure to enroll patients in clinical trials has never been greater, and never more dependent on sophisticated patient recruitment organizations (PRO). How are PROs meeting this challenge? With improved data mining, targeted patient outreach, and close attention to metrics. PROs are ensuring that the proper time is devoted to planning prior to project execution to... Read More »

Super-charged Screening for Patient Enrollment

To support our commitment to achieving patient enrollment certainty, Acurian leverages proprietary software to pre-screen trial candidates across multiple clinical studies simultaneously. This methodology is steeped in our tradition of technology and patient-first feasibility, representing a time-tested model to bring the right patients to the right studies – even across an entire portfolio with many different indications or protocols. Acurian on: Super-charged Screening... Read More »

Patient Concierge

Representing a level of personal service that goes “above and beyond,” a Patient Concierge program is designed to provide a single point of contact to help patients and caregivers navigate the complexities of clinical trial participation. It can mitigate patients’ concerns or objections, enhance the patient experience, and increase patient satisfaction. Acurian On: Patient Concierge Read More »

Technology in Patient Recruitment

Wearables…smartphones…social networks…the list of new technological tools available to patients and healthcare providers goes on and on. Many clinical trial sponsors are still trying to sort out what role these exciting developments will play in the future of patient recruitment. One thing is for sure: despite the allure of bright, shiny objects, there’s no one... Read More »

Opportunity Costs

Clinical trials can bring new innovations to the market only when they are completed with the required number of patients. The problem is that only 6 percent of clinical trials are completed on time, and 80 percent of trials are delayed by at least one month. Additionally, 37 percent of all sites in any given... Read More »

How to Avoid the Five Patient Enrollment Mistakes That Delay Clinical Trials

Ever wonder why 80% of clinical trials are delayed? The top reason is unfulfilled enrollment, and there are specific reasons why this happens with so many trials. This webinar will reveal five patient enrollment errors that stall enrollment timelines in trial after trial. More importantly, it will provide useful advice, based on proven methods, for... Read More »

Site Enrollment Optimization

Bolstering Clinical Trial Enrollment with Site Support Services – It’s All about Relationships On an ongoing basis, the Patient Recruitment Organization (PRO) should provide sites with people, processes, and technology to support the enrollment and retention goals of the trial. We call this Site Enrollment Optimization, or SEO. Acurian On: Site Enrollment Optimization Read More »

Alzheimer’s: A Path Toward A Cure

Every major health epidemic has seemed daunting and insurmountable, until a single momentous discovery – or more often, a critical mass of accumulated knowledge – tips the balance toward a decisive treatment or cure. Vaccines that took a hundred years to conceive are now viewed as a matter of routine care. Cancers that claimed every... Read More »

Patient Attrition in Clinical Trial Enrollment

“Why does it seem so hard to recruit patients for a trial outside of my selected clinical site practices?” This is a question that Patient Recruitment Organizations (PROs) hear all the time from sponsors, particularly when it is increasingly difficult for the principal investigators (PIs) to source the majority of patients. The challenges of recruiting and enrolling patients unknown to the... Read More »

The Global Alzheimer’s Crisis: New Paradigms in Clinical Trials and Longitudinal Screening

There is scientific knowledge. And there is public perception. And often, the two collide. Nowhere is this reality more explicit than with the current state of Alzheimer’s disease research. Without a definitive cause or diagnosis – and no cure in sight – many adults see no reason to assess their risk, or determine their cognitive... Read More »